News & Alerts
-
Nov- 2023 -2 November
Hikma Pharma Projects Strong Core Operating Margin Growth, Fueled by Sodium Oxybate Success
Hikma Pharmaceuticals, a prominent pharmaceutical company listed on the London Stock Exchange (HIK.L), has recently announced its financial outlook, and…
Read More » -
1 November
South Rampart Pharma Broadens Global Patent Portfolio with EU Endorsement for FDA Fast-Tracked Pain Relief SRP-001
South Rampart Pharma, a clinical-stage life science company focused on innovative pain treatments, has expanded its global patent portfolio with…
Read More » -
1 November
Navamedic ASA Achieves Record Quarter with Over 50% Growth
Navamedic ASA, a Nordic pharmaceutical company known for providing high-quality products to hospitals and pharmacies, has announced its financial results…
Read More » -
1 November
Soterios Pharma Wraps Up Phase II Enrollment for STS-01 in Alopecia Areata
Soterios Pharma, a clinical-stage pharmaceutical company, has announced the completion of target enrollment for its Phase II trial with STS-01,…
Read More » -
1 November
FDA Warns of Dangerous Lead Levels in WanaBana Apple Cinnamon Fruit Puree Pouches for Children
The U.S. Food and Drug Administration (FDA) has issued a warning about certain pureed fruit pouches from WanaBana, cautioning that…
Read More » -
1 November
Biden Administration Urges Schools to Stock Naloxone, the Lifesaving Opioid Overdose Treatment
In a significant move, the Biden administration is encouraging schools across the United States to have naloxone readily available, a…
Read More » -
1 November
FDA Approves Wezlana as an Interchangeable Biosimilar to Stelara for Multiple Inflammatory Diseases
The U.S. Food and Drug Administration (FDA) has granted approval to Wezlana (ustekinumab-auub) as an interchangeable biosimilar to Stelara (ustekinumab)…
Read More » -
Oct- 2023 -31 October
Hengrui Pharma Teams Up with Merck KGaA for Cancer Therapies
Jiangsu Hengrui Pharmaceuticals Co., Ltd (Hengrui Pharma), a globally recognized pharmaceutical company known for its commitment to scientific and technological…
Read More » -
31 October
Next-Generation Sequencing Market Set to Grow by USD 3.41 Billion from 2022 to 2027 at a CAGR of 12.45% – Technavio
According to a recent market study by Technavio, the Next-Generation Sequencing (NGS) market is anticipated to witness significant growth, with…
Read More » -
31 October
EGFR Inhibitors Market to Surge by USD 6.75 Billion by 2028, Led by North America – Report
The global market for Epidermal Growth Factor Receptor (EGFR) inhibitors is projected to witness remarkable growth, surging by USD 6.75…
Read More »